1. Patient specific dosing in a phase I cancer trial;Babb;Statistics in Medicine,2001
2. The bivariate continual reassessment method: Extending the CRM to phase I trials of two competing outcomes;Braun;Controlled Clinical Trials,2002
3. Approaches for optimal sequential decision analysis in clinical trials;Carlin;Biometrics,1998
4. Couriel , D. Champlin , R. Ippoliti , C. et al 2001 A sequentially adaptive, open-label, dose finding, phase I/II trial of Pentostatin in the treatment of steroid-refractory acute graft-versus-host disease (aGVHD)
5. deLima , M. Champlin , R. Kantarjian , H. et al 2001 Allogeneic stem cell transplantation using Mylotary plus nonmyeloablative chemotherapy in older or medically infirm patients with high-risk acute leukemia, chronic myelogenous leukemia or myelodysplastic syndrome